Coverage levels for three doses of DTP-containing vaccine, measles-containing vaccine down to lowest levels since 2008
HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
Please see our Editorial and Fact-Checking Policy for more detail.
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
THURSDAY, Nov. 3, 2022 (HealthDay News) — Routine vaccination coverage decreased worldwide in 2021, according to research published in the Nov. 4 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Audrey Rachlin, Ph.D., from the CDC in Atlanta, and colleagues updated a 2020 report with global, regional, and national vaccination coverage estimates and trends through 2021.
The researchers observed a decrease in global estimates of coverage with three doses of diphtheria-tetanus-pertussis-containing vaccine (DTPcv3), from an average of 86 percent during 2015 to 2019 to 83 and 81 percent in 2020 and 2021, respectively. Worldwide, 25.0 million infants (19 percent of the target population) were not vaccinated with DTPcv3 in 2021, which was 2.1 and 5.9 million more than in 2020 and 2019, respectively. The number of infants who did not receive any DTPcv dose by age 12 months was 37 percent higher in 2021 than 2019 (18.2 million versus 13.3 million). There was a decrease in coverage with the first dose of measles-containing vaccine (MCV1) from an average of 85 percent in 2015 to 2019 to 84 and 81 percent in 2020 and 2021, respectively. The coverage levels for DTPcv3 and MCV1 were the lowest since 2008. For bacillus Calmette-Guérin vaccine, the completed series of Haemophilus influenzae type b vaccine, hepatitis B vaccine, polio vaccine, and rubella-containing vaccine global coverage estimates were also lower in 2021 than 2020 and 2019.
"Reversing worrisome vaccination trends and extending previous gains in coverage beyond prepandemic levels will require targeted and context-specific approaches to eliminate barriers to vaccination, particularly in communities with large populations of zero-dose children," the authors write.
Abstract/Full Text
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at solutions@healthday.com with any questions.
Physician’s Briefing Staff
Published on November 03, 2022
Copyright © 2020 HealthDay.
All rights reserved.
This website is certified by Health On the Net Foundation. Click to verify.

source